Pharmaceutical Agents: Topical and Oral Therapeutic Privileges and Limits
Pharmaceutical agents: topical and oral therapeutic privileges and limitations
This domain tests the extent and limits of Maryland optometric prescribing. Questions often distinguish diagnostic from therapeutic use and topical from oral agents.
Core rules
Maryland optometrists may use topical and oral pharmaceutical agents for diagnostic and therapeutic purposes within the scope of optometric practice, subject to Board regulation and standards of care. Typical agents include topical anti-infectives, anti-inflammatory agents, glaucoma medications, and oral antibiotics or antivirals for ocular conditions. Authority is not unlimited: optometrists do not prescribe for unrelated systemic disease, do not perform surgery, and must comply with controlled-substance requirements, including DEA registration where applicable. Prescribing must follow an appropriate history and examination, with documentation of the indication, dose, and follow-up. State law and federal law both apply; a Maryland privilege does not excuse a federal violation. Dispensing is generally limited to samples or office-administered agents unless separately authorized.
Worked example
A patient has a painful vesicular rash in the V1 distribution with early corneal involvement. The optometrist diagnoses herpes zoster ophthalmicus, starts an oral antiviral, provides topical care, and refers promptly for co-management. Reasoning: oral antiviral therapy for an ocular condition is within the therapeutic privilege, but the corneal involvement and risk of complications require referral and documented follow-up.
Traps that cost marks
Do not assume 'oral' means any drug for any condition. Do not forget DEA registration and prescription-monitoring rules for controlled substances. Do not prescribe to yourself or close family outside accepted care. Do not overlook allergy, pregnancy, and drug-interaction checks. Do not document a diagnosis without recording the examination that supports it.